Identification and Validation of an Immune-Associated RNA-Binding Proteins Signature to Predict Clinical Outcomes and Therapeutic Responses in Glioma Patients
The prognosis of patients with glioma is largely related to both the tumor-infiltrating immune cells and the expression of RNA-binding proteins (RBPs) that are able to regulate various pro-inflammatory and oncogenic mediators. However, immune-associated RBPs in glioma remain unexplored. In this stud...
Main Authors: | Ruotong Tian, Yimin Li, Qian Liu, Minfeng Shu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/7/1730 |
Similar Items
-
Prognosis Analysis and Validation of m6A Signature and Tumor Immune Microenvironment in Glioma
by: Shaojian Lin, et al.
Published: (2020-10-01) -
The Predictive Value of Monocytes in Immune Microenvironment and Prognosis of Glioma Patients Based on Machine Learning
by: Nan Zhang, et al.
Published: (2021-04-01) -
An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas
by: Hongbo Zhang, et al.
Published: (2020-12-01) -
Development and validation of an immune‐related prognostic signature in lung adenocarcinoma
by: Sijin Sun, et al.
Published: (2020-08-01) -
An Immune Gene-Related Five-lncRNA Signature for to Predict Glioma Prognosis
by: Xinzhuang Wang, et al.
Published: (2020-12-01)